FDA Inspection 1309464 - Fougera Pharmaceuticals, Inc. - March 26, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Fougera Pharmaceuticals, Inc., with an inspection on March 26, 2026, issued by the New York District Office, covering human drugs.

Company: Fougera Pharmaceuticals, Inc.
Inspection Date: March 26, 2026
Product Type: Human Drugs
Office: New York District Office

Open in Dashboard

ID · 0a2352b7-37fb-4c97-801b-4cfa3f327b63

Violation Codes1

21 CFR 211.67(a)

Full citation text and observation details available on the Dashboard.